Okada commits to India’s health-related issues
Kyoto’s OMRON Healthcare Co Ltd is to establish a manufacturing factory in Tamil Nadu, to begin manufacturing blood pressure monitors in March 2025.
Ayumu Okada, President and CEO of OMRON Healthcare, said on 2 Jun 2023, “The establishment of the manufacturing factory will help us to strengthen the supply chain of blood pressure monitors while exploring the solutions for the disease management and early disease detection before it worsens.
“For realizing the vision of ‘Going for ZERO,’ the company is committed to contributing to the health-related issues of the country.
“Due to the rapid economic and population growth in India, the number of patients suffering from lifestyle diseases such as hypertension is expected to increase,” he noted.
Regular blood pressure monitoring at home is considered to be essential in hypertensive management.
However, the penetration rate of blood pressure monitors in India remains low at around 2%.
India expects an average GDP annual growth rate of around 6% until 2030 and the population is expected to reach 1.66 billion in 2050.
Owing to the accelerating economic growth and acute population growth, India has now seen a rise in the number of lifestyle disease patients.
Among these types of diseases, hypertension is one of the most common causes of cerebro-cardiovascular diseases such as stroke and heart failure, said the company.
The establishment of the manufacturing factory and the steady distribution structure are the company’s efforts to deliver blood pressure monitors to as many people as possible in India.
The company believes these initiatives along with a series of disease education campaigns will provide health-related solutions to the people in India.
The company strives to strengthen the reach and availability of home blood pressure monitors across the country and has committed to fulfilling the vision of “Going for ZERO” (achieving zero cerebro-cardiovascular events). Fiinews.com
